Clinical trial
Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks
NCT00279617 · Lindner Center of HOPE, Other · Completed
Key facts
| NCT number | NCT00279617 |
|---|---|
| Title | Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks |
| Official title | Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks |
| Lead sponsor | Lindner Center of HOPE, Other |
| Collaborators | UCB Pharma Industry University of Cincinnati |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Panic Disorder |
| Intervention type | Drug |
| Interventions | levetiracetam |
| Enrollment | 15 |
| Start date | Jan 1, 2006 |
| Primary completion | Feb 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Jan 19, 2006 |
| Last update posted | Dec 13, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: